Sunday Nov 03, 2024
FT
Sunday Nov 03, 2024
Thursday, 10 February 2022 00:05 - - {{hitsCtrl.values.hits}}
|
Sudarshan Jain
|
Sunshine Holdings has announced the appointment of Sudarshan Jain to the company’s board as Independent Non-Executive Director.
With the new appointment, the Board of Sunshine Holdings will be comprised of nine directors, six of which are non-executive, independent directors.
Former Managing Director of Abbott Healthcare Solutions India Sudarshan Jain, is a well-respected leader counting 40 years of experience in field force management, brand building and overall business operations in the global healthcare arena. He has been associated with over 30 brands placed within the top 300 in the Indian pharmaceutical industry, across Pharmaceutical, OTC, Hospital, Diagnostic and Nutrition verticals. Over the course of his exceptional professional journey, Sudarshan has made significant contributions towards shaping healthcare policy and improving access to healthcare in India, garnering numerous recognitions, a highlight being the receipt of the Global Chairman’s Award at Abbott as its first Indian Recipient.
He is currently Secretary General of the Indian Pharmaceutical Alliance (IPA), Senior Advisor with APAX Partners, Chairman of Indian Institute of Health Management and Research (IIHMR, Jaipur), in addition to serving on the board of multiple organisations. Sudarshan is an alumnus of St. Stephens College India and the Delhi and Indian Institute of Management.
With the latest appointment the Board of Directors of Sunshine Holdings Plc comprises Amal Cabraal (Chairman), Vish Govindasamy (Group Managing Director), S. Ratwatte, H.D. Abeywickrama, A.D.B. Talwatte, S. Shishoo, G. Sathasivam, S.G. Sathasivam and S. Jain.
Sunshine Holdings PLC is a diversified conglomerate contributing to ‘nation-building’ by creating value in vital sectors of the Sri Lankan economy – healthcare, consumer products and agribusiness.
